Cite

HARVARD Citation

    McNulty, M. et al. (n.d.). P-147Use of gemcitabine and nab-paclitaxel as a third-line treatment following failure of first line gemcitabine for advanced pancreatic adenocarcinoma. Annals of oncology. p. . [Online]. 
  
Back to record